Neogen (NEOG) Competitors $4.95 -0.45 (-8.33%) Closing price 04:00 PM EasternExtended Trading$4.89 -0.06 (-1.11%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NEOG vs. MMSI, ICUI, HAE, XRAY, QDEL, STAA, CERS, OSUR, ANIK, and UTMDShould you be buying Neogen stock or one of its competitors? The main competitors of Neogen include Merit Medical Systems (MMSI), ICU Medical (ICUI), Haemonetics (HAE), DENTSPLY SIRONA (XRAY), QuidelOrtho (QDEL), STAAR Surgical (STAA), Cerus (CERS), OraSure Technologies (OSUR), Anika Therapeutics (ANIK), and Utah Medical Products (UTMD). These companies are all part of the "health care supplies" industry. Neogen vs. Merit Medical Systems ICU Medical Haemonetics DENTSPLY SIRONA QuidelOrtho STAAR Surgical Cerus OraSure Technologies Anika Therapeutics Utah Medical Products Neogen (NASDAQ:NEOG) and Merit Medical Systems (NASDAQ:MMSI) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, earnings, dividends, profitability, risk, valuation, analyst recommendations and community ranking. Does the MarketBeat Community believe in NEOG or MMSI? Merit Medical Systems received 117 more outperform votes than Neogen when rated by MarketBeat users. Likewise, 70.05% of users gave Merit Medical Systems an outperform vote while only 56.56% of users gave Neogen an outperform vote. CompanyUnderperformOutperformNeogenOutperform Votes33256.56% Underperform Votes25543.44% Merit Medical SystemsOutperform Votes44970.05% Underperform Votes19229.95% Do insiders and institutionals believe in NEOG or MMSI? 96.7% of Neogen shares are held by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are held by institutional investors. 1.1% of Neogen shares are held by insiders. Comparatively, 3.7% of Merit Medical Systems shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Do analysts recommend NEOG or MMSI? Neogen presently has a consensus price target of $9.75, suggesting a potential upside of 94.03%. Merit Medical Systems has a consensus price target of $114.33, suggesting a potential upside of 23.00%. Given Neogen's higher possible upside, analysts clearly believe Neogen is more favorable than Merit Medical Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Neogen 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Merit Medical Systems 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has higher valuation and earnings, NEOG or MMSI? Merit Medical Systems has higher revenue and earnings than Neogen. Neogen is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeogen$906.00M1.20-$9.42M-$2.23-2.25Merit Medical Systems$1.36B4.05$94.41M$2.0345.79 Is NEOG or MMSI more profitable? Merit Medical Systems has a net margin of 9.05% compared to Neogen's net margin of -52.12%. Merit Medical Systems' return on equity of 15.61% beat Neogen's return on equity.Company Net Margins Return on Equity Return on Assets Neogen-52.12% 2.89% 1.98% Merit Medical Systems 9.05%15.61%8.38% Which has more risk & volatility, NEOG or MMSI? Neogen has a beta of 1.57, indicating that its stock price is 57% more volatile than the S&P 500. Comparatively, Merit Medical Systems has a beta of 0.85, indicating that its stock price is 15% less volatile than the S&P 500. Does the media favor NEOG or MMSI? In the previous week, Neogen had 28 more articles in the media than Merit Medical Systems. MarketBeat recorded 53 mentions for Neogen and 25 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.17 beat Neogen's score of 0.25 indicating that Merit Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Neogen 9 Very Positive mention(s) 8 Positive mention(s) 16 Neutral mention(s) 11 Negative mention(s) 1 Very Negative mention(s) Neutral Merit Medical Systems 15 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive SummaryMerit Medical Systems beats Neogen on 16 of the 19 factors compared between the two stocks. Remove Ads Get Neogen News Delivered to You Automatically Sign up to receive the latest news and ratings for NEOG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NEOG vs. The Competition Export to ExcelMetricNeogenDiagnostic substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.09B$2.32B$5.36B$7.63BDividend YieldN/A0.78%5.11%4.33%P/E Ratio-2.296.1021.7617.88Price / Sales1.2046.17381.6595.73Price / Cash9.8015.7538.1534.64Price / Book0.352.936.484.02Net Income-$9.42M-$65.73M$3.20B$247.22M7 Day Performance-28.62%8.56%6.97%7.00%1 Month Performance-44.48%-15.29%-8.33%-6.42%1 Year Performance-58.16%-19.86%10.06%-0.03% Neogen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NEOGNeogen3.2346 of 5 stars$4.95-8.3%$9.75+97.0%-56.4%$1.07B$906.00M-2.262,110Earnings ReportAnalyst ForecastAnalyst RevisionHigh Trading VolumeMMSIMerit Medical Systems4.4891 of 5 stars$92.51+0.0%$111.70+20.7%+28.4%$5.46B$1.36B45.356,950Short Interest ↓Positive NewsHigh Trading VolumeICUIICU Medical3.7824 of 5 stars$142.25+2.1%$168.67+18.6%+43.1%$3.49B$2.38B-31.1314,500Positive NewsGap DownHAEHaemonetics4.6255 of 5 stars$58.96-3.2%$101.22+71.7%-30.4%$2.96B$1.37B23.212,820Short Interest ↓Positive NewsGap DownXRAYDENTSPLY SIRONA4.8133 of 5 stars$13.24-2.5%$23.33+76.2%-58.2%$2.63B$3.79B-6.4015,000Analyst DowngradeNews CoveragePositive NewsGap DownQDELQuidelOrtho4.3836 of 5 stars$28.36+0.8%$51.20+80.5%-35.3%$1.91B$2.78B-0.947,000High Trading VolumeSTAASTAAR Surgical4.2856 of 5 stars$16.14+1.4%$25.29+56.7%-65.3%$796.11M$313.90M-39.37960Positive NewsGap DownCERSCerus2.5736 of 5 stars$1.24flat$4.00+222.6%-22.3%$230.38M$180.27M-11.27290Positive NewsOSUROraSure Technologies4.6794 of 5 stars$3.01-3.2%$5.50+82.7%-45.7%$225.15M$185.83M20.07840News CoveragePositive NewsANIKAnika Therapeutics3.9384 of 5 stars$13.92-0.6%$22.00+58.0%-44.4%$197.33M$119.91M-2.09300News CoverageGap DownUTMDUtah Medical Products2.9867 of 5 stars$54.39-0.8%N/A-22.3%$178.51M$40.90M13.77180News CoveragePositive News Remove Ads Related Companies and Tools Related Companies MMSI Competitors ICUI Competitors HAE Competitors XRAY Competitors QDEL Competitors STAA Competitors CERS Competitors OSUR Competitors ANIK Competitors UTMD Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NEOG) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neogen Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.